| 3.09 Delayed Data As of Aug 22 |  -0.01 / -0.32%Today’s Change | 2.83 Today|||52-Week Range 27.60 | -52.89% Year-to-Date |
| Previous close | 3.10 |
| Today’s open | 3.11 |
| Day’s range | 3.00 - 3.15 |
| Volume | 28,280 |
| Average volume (3 months) | 59,888 |
| Market cap | $29.3M |
| Earnings growth (last year) | +22.49% |
| Earnings growth (this year) | +15.13% |
| Earnings growth (next 5 years) | -25.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| EDSAEdesa Biotech Inc | -0.01 | -0.25% |
| PDSBPDS Biotechnology Co... | +0.05 | +0.85% |
| DMACDiaMedica Therapeuti... | -0.07 | -2.69% |
| SPHSSophiris Bio Inc | -0.02 | -1.81% |
| Next reporting date | November 19, 2019 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$22.9M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer Philip Adam Serlin |
Chief Financial Officer Mali Zeevi |
Corporate headquarters Modi'in, Tel Aviv |
